0.93
-0.0473(-4.83%)
Currency In USD
| Previous Close | 0.98 |
| Open | 0.96 |
| Day High | 0.96 |
| Day Low | 0.91 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.26 |
| Volume | 303,996 |
| Average Volume | 1.86M |
| Market Cap | 171.44M |
| PE | -13.32 |
| EPS | -0.07 |
| Moving Average 50 Days | 1.21 |
| Moving Average 200 Days | 1.06 |
| Change | -0.05 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $93.79 as of April 22, 2025 at a share price of $0.932. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $88.71 as of April 22, 2025 at a share price of $0.932.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility
GlobeNewswire Inc.
Apr 17, 2025 6:54 PM GMT
The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilitiesFormalized agreement aligns with previously announced topline forecasts WARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen B
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
GlobeNewswire Inc.
Apr 15, 2025 6:03 PM GMT
WARREN, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced the commission of Databricks, Inc., a leader in data, analytics and artificial intelligence (AI), with an aim to acc
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
GlobeNewswire Inc.
Apr 14, 2025 5:53 PM GMT
WARREN, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announces CEO Dr. Ryan Saadi, MD, MPH, will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will